ETN CPD - Worming Answers September 2017

A) Benzimidazoles
B) Macrocyclic lactones
C) Tetrahydropyrimidines
A) Benzimidazoles
B) Macrocyclic lactones
C) Tetrahydropyrimidines
A) Increased worming frequency
B) Under-dosing
C) Infrequent poo-picking
D) Rotating class of worming drug used
A) Stronglyus vulgaris
B) Cyathostomins
C) Ascarids
D) Pin worm
A) 10%
B) 20%
C) 30%
D) 50%
A) In the blood vessels
B) In the wall of the large intestine
C) In the liver
D) In the lungs
A) Ivermectin and moxidectin
B) Ivermectin and fenbendazole
C) Moxidectin and fenbendazole
D) Fenbendazole and pyrantel
A) 10-20% of the population
B) 30-40% of the population
C) 50-60% of the population
D) 80-100% of the population
A) Moxidectin or Pyrantel
B) Double dose of pyrantel or fenbendazole
C) Pryantel (standard dose) or praziquantel
D) Double dose of pyrantel or praziquantel
A) A faecal egg count
B) A saliva test
C) A blood test
D) Currently there is no available test to diagnose larval stages of cyathostomin infections